We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$1.12B
AUM Growth
+$94.2M
Cap. Flow
+$29.6M
Cap. Flow %
2.64%
Top 10 Hldgs %
29.81%
Holding
2,679
New
140
Increased
832
Reduced
416
Closed
65

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$28.1M
2
SCHP icon
Schwab US TIPS ETF
SCHP
+$5.31M
3
FIW icon
First Trust Water ETF
FIW
+$4.03M
4
RDVY icon
First Trust Rising Dividend Achievers ETF
RDVY
+$3.49M
5
VOE icon
Vanguard Morningstar Mid-Cap Value ETF
VOE
+$3.19M

Top Sells

Rank Stock Value
1
FPX icon
First Trust US Equity Opportunities ETF
FPX
+$8.47M
2
VOT icon
Vanguard Morningstar Mid-Cap Growth ETF
VOT
+$3.98M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$3.04M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$2.55M
5
IWP icon
iShares Russell Mid-Cap Growth ETF
IWP
+$1.99M

Sector Composition

Rank Sector Weight
1 Technology 5.59%
2 Healthcare 3.03%
3 Financials 2.86%
4 Industrials 2.37%
5 Consumer Discretionary 2.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALC icon
1551
Alcon
ALC
$33.9B
$7.15K ﹤0.01%
71
– –
DGX icon
1552
Quest Diagnostics
DGX
$26.3B
$7.14K ﹤0.01%
46
+21
+84% +$3.14K
OXM icon
1553
Oxford Industries
OXM
$560M
$7.12K ﹤0.01%
82
-5
-6% -$460
TRI icon
1554
Thomson Reuters
TRI
$43.4B
$7.11K ﹤0.01%
41
-864
-95% -$146K
AMLX icon
1555
Amylyx Pharmaceuticals
AMLX
$2.7B
$7.11K ﹤0.01%
2,193
– –
CPRX
1556
DELISTED
Catalyst Pharmaceutical
CPRX
$7.08K ﹤0.01%
356
– –
IJS icon
1557
iShares S&P Small-Cap 600 Value ETF
IJS
$8.26B
$7.04K ﹤0.01%
65
– –
UBSI icon
1558
United Bankshares
UBSI
$6.65B
$7.01K ﹤0.01%
189
– –
PATK icon
1559
Patrick Industries
PATK
$2.87B
$6.98K ﹤0.01%
74
+50
+208% +$4.19K
PCVX icon
1560
Vaxcyte
PCVX
$8.76B
$6.97K ﹤0.01%
61
+9
+17% +$811
HHH icon
1561
Howard Hughes
HHH
$4.06B
$6.97K ﹤0.01%
90
-4
-4% -$283
AHCO icon
1562
AdaptHealth
AHCO
$806M
$6.96K ﹤0.01%
620
– –
EXLS icon
1563
EXL Service
EXLS
$5.25B
$6.94K ﹤0.01%
182
– –
FLDR icon
1564
Fidelity Low Duration Bond Factor ETF
FLDR
$1.98B
$6.94K ﹤0.01%
138
+2
+1% +$100
ARQT icon
1565
Arcutis Biotherapeutics
ARQT
$3.32B
$6.92K ﹤0.01%
744
-25
-3% -$247
FRME icon
1566
First Merchants
FRME
$2.69B
$6.92K ﹤0.01%
186
– –
JQUA icon
1567
JPMorgan US Quality Factor ETF
JQUA
$8.4B
$6.9K ﹤0.01%
122
– –
CMPR icon
1568
Cimpress
CMPR
$2.34B
$6.88K ﹤0.01%
84
– –
RITM icon
1569
Rithm Capital
RITM
$5.55B
$6.88K ﹤0.01%
606
– –
CYTK icon
1570
Cytokinetics
CYTK
$11B
$6.86K ﹤0.01%
130
+19
+17% +$1.06K
LUMN icon
1571
Lumen
LUMN
$6.09B
$6.84K ﹤0.01%
964
– –
ASC icon
1572
Ardmore Shipping
ASC
$695M
$6.84K ﹤0.01%
378
– –
ENV
1573
DELISTED
ENVESTNET, INC.
ENV
$6.83K ﹤0.01%
109
– –
MRNA icon
1574
Moderna
MRNA
$21.5B
$6.82K ﹤0.01%
102
– –
SKT icon
1575
Tanger
SKT
$4.52B
$6.8K ﹤0.01%
205
– –
61 62
63
64 65

Similar funds

TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
WWA
WCG Wealth Advisors Las Vegas, Nevada $3.57B AUM 18.63% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BPS
BNDES Participacoes SA Rio De Janeiro, Brazil $3.58B AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return

Arax Advisory Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Arax Advisory Partners held 2,679 positions worth $1.12B, up 9.2% from $1.03B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Arax Advisory Partners's Q3 2024 filing shows 140 new, 832 increased, 416 reduced and 65 closed positions. Its largest new stake was iShares MSCI KLD 400 Social ETF: 739 shares worth $80.4K. The largest sale was First Trust US Equity Opportunities ETF, an estimated $8.47M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 5.6% a quarter earlier, followed by Healthcare and Financials.

  • Arax Advisory Partners's largest Q3 2024 buy was iShares MSCI KLD 400 Social ETF: 739 shares worth $80.4K.
  • Arax Advisory Partners added most to iShares Core US Aggregate Bond ETF in Q3 2024, an estimated $28.1M increase.
  • Arax Advisory Partners's biggest Q3 2024 reduction was First Trust US Equity Opportunities ETF, cutting an estimated $8.47M.
  • Arax Advisory Partners fully exited Vanguard Short-Term Inflation-Protected Securities Index Fund in Q3 2024, selling an estimated $259K.
  • Arax Advisory Partners's ten largest holdings make up 30% of its $1.12B portfolio in Q3 2024.
  • Arax Advisory Partners opened 140 new positions and closed 65 in Q3 2024.
  • Arax Advisory Partners's portfolio value rose 9.2% quarter-over-quarter to $1.12B.

Based on Arax Advisory Partners's 13F filing for Q3 2024, filed 6 Nov 2024.